Related Experiment Videos
[Cerebral venous thrombosis and factor V Leiden mutation]
1Department of Neurology, Chinese PLA General Hospital, Beijing 100853, China.
Zhonghua Yi Xue Za Zhi
|April 16, 2002
Summary
Factor V Leiden mutation is not a significant risk factor for cerebral venous thrombosis in the Chinese population. This genetic mutation was not detected in patients or controls studied.
Area of Science:
- Genetics
- Hematology
- Neurology
Context:
- Cerebral venous thrombosis (CVT) is a rare but serious condition.
- The role of genetic factors, such as factor V Leiden mutation, in CVT pathogenesis is under investigation.
- Prevalence of genetic risk factors may vary across different ethnic groups.
Purpose:
- To determine the association between factor V Leiden mutation and cerebral venous thrombosis (CVT) specifically in the Chinese population.
- To investigate the frequency of factor V Leiden mutation in Chinese patients diagnosed with CVT compared to healthy controls.
Summary:
- A study involving 20 Chinese patients with CVT and 50 controls was conducted.
- Polymerase chain reaction (PCR) and Mnl I restriction enzyme analysis were used to screen for the factor V Leiden mutation.
- The factor V Leiden mutation was absent in all participants, indicating no genetic link in this cohort.
Impact:
- This research suggests that factor V Leiden mutation is unlikely to be a primary genetic risk factor for cerebral venous thrombosis in China.
- Findings contribute to understanding the genetic landscape of CVT in East Asian populations.
- May inform future diagnostic and risk stratification strategies for CVT.